{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Targeted&page=29", "query": { "intervention": "Targeted", "page": 29 }, "page_size": 10 }, "pagination": { "page": 29, "page_size": 10, "total_count": 8418, "total_pages": 842, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Targeted&page=30&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Targeted&page=28&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-25T18:05:56.805Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04832854", "title": "A Study Evaluating the Safety and Efficacy of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Participants With Previously Untreated Locally Advanced Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Non-Small Cell Lung Cancer (NSCLC)" ], "interventions": [ { "name": "Atezolizumab", "type": "DRUG" }, { "name": "Tiragolumab", "type": "DRUG" }, { "name": "Carboplatin", "type": "DRUG" }, { "name": "Cisplatin", "type": "DRUG" }, { "name": "Pemetrexed", "type": "DRUG" }, { "name": "Gemcitabine", "type": "DRUG" }, { "name": "Paclitaxel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 50, "start_date": "2021-04-23", "completion_date": "2025-03-05", "has_results": true, "last_update_posted_date": "2026-03-11", "last_synced_at": "2026-10-25T18:05:56.805Z", "location_count": 6, "location_summary": "Duarte, California • Los Angeles, California • St Louis, Missouri + 2 more", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Mineola", "state": "New York" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04832854" }, { "nct_id": "NCT05899153", "title": "Gait Adaptation and Biofeedback for Cerebral Palsy", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cerebral Palsy" ], "interventions": [ { "name": "Biomotum Spark: Robotic ankle resistance", "type": "DEVICE" }, { "name": "Audiovisual Biofeedback", "type": "DEVICE" }, { "name": "Multilevel Orthopedic Surgery", "type": "PROCEDURE" } ], "intervention_types": [ "DEVICE", "PROCEDURE" ], "sponsor": "University of Washington", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "7 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "7 Years to 18 Years" }, "enrollment_count": 36, "start_date": "2023-11-28", "completion_date": "2029-01-01", "has_results": false, "last_update_posted_date": "2026-06-08", "last_synced_at": "2026-10-25T18:05:56.805Z", "location_count": 1, "location_summary": "Saint Paul, Minnesota", "locations": [ { "city": "Saint Paul", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT05899153" }, { "nct_id": "NCT06325202", "title": "Closed Loop and Education for Hypoglycemia Awareness Restoration", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diabetes Mellitus, Type 1" ], "interventions": [ { "name": "Omnipod 5 or Medtronic 780G", "type": "DEVICE" }, { "name": "My HypoCOMPaSS Education", "type": "BEHAVIORAL" }, { "name": "HARPdoc Education", "type": "BEHAVIORAL" } ], "intervention_types": [ "DEVICE", "BEHAVIORAL" ], "sponsor": "Milton S. Hershey Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 324, "start_date": "2025-10-03", "completion_date": "2029-07-31", "has_results": false, "last_update_posted_date": "2026-03-03", "last_synced_at": "2026-10-25T18:05:56.805Z", "location_count": 5, "location_summary": "La Jolla, California • Orlando, Florida • Lexington, Kentucky + 2 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "Orlando", "state": "Florida" }, { "city": "Lexington", "state": "Kentucky" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT06325202" }, { "nct_id": "NCT04173572", "title": "Targeting Physical Health in Schizophrenia: Physical Activity Can Enhance Life Randomized Control Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Schizophrenia", "Schizoaffective Disorder", "Brief Psychotic Disorder", "Schizophreniform Disorders", "Unspecified Schizophrenia Spectrum and Other Psychotic Disorder" ], "interventions": [ { "name": "PACE-Life", "type": "BEHAVIORAL" }, { "name": "Exercise Intervention", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of North Carolina, Chapel Hill", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 50, "start_date": "2019-12-20", "completion_date": "2022-03-23", "has_results": true, "last_update_posted_date": "2022-09-22", "last_synced_at": "2026-10-25T18:05:56.805Z", "location_count": 2, "location_summary": "Chapel Hill, North Carolina • Raleigh, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" }, { "city": "Raleigh", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT04173572" }, { "nct_id": "NCT04594941", "title": "A Study of Flurpiridaz (18F) Injection for PET Imaging for Assessment of MPI Quality Using HPLC and SPE Manufacturing Processes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Coronary Artery Disease (CAD)", "Ischemic Heart Disease" ], "interventions": [ { "name": "Flurpiridaz (18F) Injection", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GE Healthcare", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 38, "start_date": "2022-01-27", "completion_date": "2022-05-26", "has_results": true, "last_update_posted_date": "2023-08-01", "last_synced_at": "2026-10-25T18:05:56.805Z", "location_count": 5, "location_summary": "Hialeah, Florida • Miami, Florida • North Miami Beach, Florida + 2 more", "locations": [ { "city": "Hialeah", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "North Miami Beach", "state": "Florida" }, { "city": "Knoxville", "state": "Tennessee" }, { "city": "Katy", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04594941" }, { "nct_id": "NCT04057105", "title": "Targeted Noninvasive Brain Stimulation (T-NIBS) to Improve Hand Motor Functions in Acquired Brain Injury", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Upper Extremity Dysfunction", "Traumatic Brain Injury" ], "interventions": [ { "name": "Active High-definition Transcranial Direct Current Stimulation (HD-tDCS)", "type": "DEVICE" }, { "name": "MusicGlove", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Kessler Foundation", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 14, "start_date": "2020-10-01", "completion_date": "2024-12-30", "has_results": false, "last_update_posted_date": "2026-10-21", "last_synced_at": "2026-10-25T18:05:56.805Z", "location_count": 1, "location_summary": "West Orange, New Jersey", "locations": [ { "city": "West Orange", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT04057105" }, { "nct_id": "NCT01442129", "title": "The Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in Patients Undergoing LVAD Implantation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Heart Failure", "Cardiomyopathy", "Ventricular Dysfunction" ], "interventions": [ { "name": "MPC Intramyocardial injection", "type": "BIOLOGICAL" }, { "name": "Control Solution", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Deborah Ascheim", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2012-04", "completion_date": "2013-08", "has_results": true, "last_update_posted_date": "2015-05-01", "last_synced_at": "2026-10-25T18:05:56.805Z", "location_count": 11, "location_summary": "Gainsville, Florida • Baltimore, Maryland • Minneapolis, Minnesota + 8 more", "locations": [ { "city": "Gainsville", "state": "Florida" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "New York", "state": "New York" }, { "city": "The Bronx", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01442129" }, { "nct_id": "NCT05611229", "title": "Treatment Patterns and Outcomes of Targeted Therapy and Immunotherapy Among BRAF-Positive Melanoma Patients Treated in the Adjuvant Setting and Among BRAF-Positive Metastatic Melanoma Patients With Low Tumor Burden", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Metastatic Melanoma" ], "interventions": [ { "name": "Nivolumab", "type": "DRUG" }, { "name": "Pembrolizumab", "type": "DRUG" }, { "name": "Dabrafenib+Trametinib", "type": "COMBINATION_PRODUCT" }, { "name": "Ipilimumab+Nivolumab", "type": "COMBINATION_PRODUCT" }, { "name": "Vemurafenib+Cobimetinib", "type": "COMBINATION_PRODUCT" }, { "name": "Encorafenib+Binimetinib", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "DRUG", "COMBINATION_PRODUCT" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1975, "start_date": "2020-06-16", "completion_date": "2021-12-03", "has_results": false, "last_update_posted_date": "2023-04-06", "last_synced_at": "2026-10-25T18:05:56.805Z", "location_count": 1, "location_summary": "East Hanover, New Jersey", "locations": [ { "city": "East Hanover", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT05611229" }, { "nct_id": "NCT00671931", "title": "Susceptibility of Motor-Evoked Potentials to Varying Targeted Blood Levels of Dexmedetomidine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Scoliosis" ], "interventions": [ { "name": "low dexmedetomidine, low propofol", "type": "DRUG" }, { "name": "high dexmedetomidine, low propofol", "type": "DRUG" }, { "name": "Dexmedetomidine", "type": "DRUG" }, { "name": "Dexmedetomidin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Children's Hospital Medical Center, Cincinnati", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "25 Years", "sex": "ALL", "summary": "10 Years to 25 Years" }, "enrollment_count": 44, "start_date": "2007-04", "completion_date": "2009-01", "has_results": true, "last_update_posted_date": "2013-08-23", "last_synced_at": "2026-10-25T18:05:56.805Z", "location_count": 1, "location_summary": "Cincinnati, Ohio", "locations": [ { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00671931" }, { "nct_id": "NCT00090753", "title": "A Study of Intravenous or Subcutaneous Methoxy Polyethylene Glycol-Epoetin Beta (RO0503821, Mircera) in Chronic Kidney Disease Patients With Renal Anemia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Anemia" ], "interventions": [ { "name": "Methoxy Polyethylene Glycol-Epoetin Beta", "type": "DRUG" }, { "name": "Epoetin alfa", "type": "DRUG" }, { "name": "Epoetin beta", "type": "DRUG" }, { "name": "Darbepoetin alfa", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1228, "start_date": "2004-10", "completion_date": "2009-12", "has_results": true, "last_update_posted_date": "2012-02-14", "last_synced_at": "2026-10-25T18:05:56.805Z", "location_count": 83, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Montgomery, Alabama + 69 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" }, { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Covina", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00090753" } ] }